🔴 HCW Biologics is trading 5.5% down in after-hours trading amid broader risk-off sentiment

HCW Biologics is trading 5.5% lower at $1.72 after-hours, with broader market weakness as possible context; no company-specific announcement explaining the move was identified.

• HCW Biologics closed September 28 at $1.82, down 5.70% during the regular session.
• Reuters reported U.S. stocks fell as rising oil prices and Treasury yields, along with uncertainty over U.S.-Iran talks, weighed on investors. That backdrop may have contributed but does not establish a direct cause for this stock’s move.